Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bayer
Age
18–58
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Participant must be 18 to 58 years of age inclusive, at the time of signing the informed consent.
Participants who are overtly healthy as determined by medical evaluation, including medical history, physical examination, vital signs (blood pressure and heart rate), ECG, body temperature, and clinical laboratory tests.
Body weight of at least 60 kg and BMI within the range 18.0 - 29.9 kg/m2(inclusive) at screening.
Contraceptive use by the participant or the participant partners should be consistent with local regulations regarding the methods of contraception for those participating in clinical studies.
You may not be if
Pre-existing diseases for which it can be assumed that the absorption, distribution, metabolism, elimination, and effects of the study intervention(s) will not be normal.
Known severe allergies, e.g., allergies affecting the lower respiratory tract - allergic asthma, allergies requiring therapy with corticosteroids, urticaria or significant non-allergic drug reactions.
Acute diarrhea or constipation within 14 days before the first administration of study intervention.
Contraindications to rosuvastatin or dabigatran etexilate.
Regular use of prescription drugs (other than hormonal contraceptives), over-the-counter drugs, supplements (e.g., carnitine products, or high dose vitamins), anabolics or herbal products within the last 14 days before the first administration of study intervention.
